BIOGEN INC. - Daily - Technical analysis published on 08/29/2020 (GMT)
- 314
- 0
- Who voted?
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Additional analysis
Quotes
BIOGEN INC. rating 281.46 USD. The price registered an increase of +0.79% on the session and was traded between 278.89 USD and 281.77 USD over the period. The price is currently at +0.92% from its lowest and -0.11% from its highest.The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Near a new LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
A technical analysis in Daily of this BIOGEN INC. chart shows a bearish trend. The signals given by moving averages are 71.43% bearish. This bearish trend could slow down given the neutral signals currently being given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, Central Analyzer took into account 18 technical indicators and the result was as follows: 4 are bullish, 9 are neutral and 5 are bearish. Caution: the Central Indicators scanner currently detects an excess:
Williams %R indicator is oversold : under -80
Type : Neutral
Timeframe : Daily
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Price is back under the pivot point
Type : Bearish
Timeframe : Daily
Price is back under the pivot point
Type : Bearish
Timeframe : Weekly
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found these results:
Near support of channel
Type : Bullish
Timeframe : Daily
Near support of triangle
Type : Bullish
Timeframe : Daily
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 258.09 | 268.90 | 278.55 | 281.46 | 298.59 | 330.11 | 343.23 |
Change (%) | -8.30% | -4.46% | -1.03% | - | +6.09% | +17.28% | +21.95% |
Change | -23.37 | -12.56 | -2.91 | - | +17.13 | +48.65 | +61.77 |
Level | Major | Major | Major | - | Major | Intermediate | Major |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 273.60 | 275.99 | 277.62 | 280.01 | 281.64 | 284.03 | 285.66 |
Camarilla | 278.15 | 278.52 | 278.89 | 279.26 | 279.63 | 280.00 | 280.37 |
Woodie | 273.23 | 275.80 | 277.25 | 279.82 | 281.27 | 283.84 | 285.29 |
Fibonacci | 275.99 | 277.52 | 278.47 | 280.01 | 281.54 | 282.49 | 284.03 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 249.19 | 261.92 | 269.49 | 282.22 | 289.79 | 302.52 | 310.09 |
Camarilla | 271.49 | 273.35 | 275.21 | 277.07 | 278.93 | 280.79 | 282.65 |
Woodie | 246.62 | 260.63 | 266.92 | 280.93 | 287.22 | 301.23 | 307.52 |
Fibonacci | 261.92 | 269.67 | 274.46 | 282.22 | 289.97 | 294.76 | 302.52 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 226.26 | 244.06 | 259.38 | 277.18 | 292.50 | 310.30 | 325.62 |
Camarilla | 265.58 | 268.62 | 271.65 | 274.69 | 277.73 | 280.76 | 283.80 |
Woodie | 225.01 | 243.44 | 258.13 | 276.56 | 291.25 | 309.68 | 324.37 |
Fibonacci | 244.06 | 256.72 | 264.53 | 277.18 | 289.84 | 297.65 | 310.30 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
RSI (14): | 49.37 | |
MACD (12,26,9): | -0.6000 | |
Directional Movement: | 3.63 | |
AROON (14): | -64.29 | |
DEMA (21): | 281.70 | |
Parabolic SAR (0,02-0,02-0,2): | 304.50 | |
Elder Ray (13): | -1.19 | |
Super Trend (3,10): | 298.36 | |
Zig ZAG (10): | 281.46 | |
VORTEX (21): | 0.8700 | |
Stochastique (14,3,5): | 17.05 | |
TEMA (21): | 280.90 | |
Williams %R (14): | -74.61 | |
Chande Momentum Oscillator (20): | -11.76 | |
Repulse (5,40,3): | 0.5400 | |
ROCnROLL: | -1 | |
TRIX (15,9): | 0.0400 | |
Courbe Coppock: | 5.35 |
MA7: | 278.58 | |
MA20: | 284.16 | |
MA50: | 277.91 | |
MA100: | 292.07 | |
MAexp7: | 280.38 | |
MAexp20: | 281.93 | |
MAexp50: | 283.25 | |
MAexp100: | 286.95 | |
Price / MA7: | +1.03% | |
Price / MA20: | -0.95% | |
Price / MA50: | +1.28% | |
Price / MA100: | -3.63% | |
Price / MAexp7: | +0.39% | |
Price / MAexp20: | -0.17% | |
Price / MAexp50: | -0.63% | |
Price / MAexp100: | -1.91% |
News
Don"t forget to follow the news on BIOGEN INC.. At the time of publication of this analysis, the latest news was as follows:
- Investor Network: Biogen Inc. to Host Earnings Call
-
Red Flag Over Biogen's Expensive Drug For Rare Genetic Disease | Power Lunch | CNBC
- SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Biogen Inc. To Contact The Firm Before Imminent Lead Plaintiff Deadline
- BIIB INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Biogen Inc. and a Lead Plaintiff Deadline of December 23, 2016
- Sangamo's Genome Editing Program for Hemoglobinopathies to Transfer to Biogen's Spin-Off Bioverativ
Add a comment
Comments
0 comments on the analysis BIOGEN INC. - Daily